IP Verse

Nucleic Acid-Containing Lipid Particles And Related Methods - EP2496700

The patent EP2496700 was granted to The University OF British Columbia on Mar 1, 2017. The application was originally filed on Nov 4, 2010 under application number EP10851175A. The patent is currently recorded with a legal status of "Revoked".

EP2496700

THE UNIVERSITY OF BRITISH COLUMBIA
Application Number
EP10851175A
Filing Date
Nov 4, 2010
Status
Revoked
Jun 21, 2019
Grant Date
Mar 1, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK SHARP & DOHMEDec 1, 2017VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
WITHERS & ROGERSNov 30, 2017SYNERGY GROUPADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2004262223
INTERNATIONAL-SEARCH-REPORTUS2006219307
INTERNATIONAL-SEARCH-REPORTWO2005120461
INTERNATIONAL-SEARCH-REPORTWO2009096558
OPPOSITIONUS2006051405
OPPOSITIONUS2007042031
OPPOSITIONWO2005026372
OPPOSITIONWO2005120152
OPPOSITIONWO2006053430
OPPOSITIONWO2009127060
OPPOSITIONWO2011140627

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- KOH C.G. ET AL., "Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing", JOURNAL OF CONTROLLED RELEASE, (20090828), vol. 141, doi:doi:10.1016/j.jconrel.2009.08.019, pages 62 - 69, XP002715252
OPPOSITION- MAURER N., "Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes", Biophysical Journal, (20010531), vol. 80, no. 5, pages 2310 - 2326, XP002589197-
OPPOSITION- MICKLEFIELD J., "Backbone modification of nucleic acids: synthesis, structure and therapeutic applications", Curr Med Chem, (20010800), vol. 8, no. 10, pages 1157 - 1179, XP002365763-
OPPOSITION- STROOK, A. et al., Science, (20020000), vol. 295, no. 2002, pages 647 - 651-
OPPOSITION- "Surround", Cowie A. P., Oxford Advanced Learner's Dictionary of Current English, Oxford University Press, (19880000), page 1188, XP055441784-
OPPOSITION- UNER, M. et al., "Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspective", International Journal of Nanomedicine 2007, (20070000), vol. 2, no. 3, pages 289 - 300, XP009109033-
OPPOSITION- UNER, M., "Preparation, characterization and physico-chemical properties ofSolid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC):Their benefits as colloidal drug carrier systems", Pharmazie, (20060000), vol. 61, pages 375 - 386, XP055438566-
OPPOSITION- ZIMMERMANN, T. S. et al., Nature, (20060000), vol. 441-
OPPOSITION- JEFFS, L. B. et al., "A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA", Pharmaceutical Research, (20050301), vol. 22, no. 3, pages 362 - 372, XP002422317
OPPOSITION- JEFFS LB et al., "A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA", Pharm Res, (20050321), vol. 22, no. 3, pages 362 - 372, XP019370801
OPPOSITION- ZHANG, S. et al., "Preparation of solid lipid nanoparticles in co-flowing microchannels", Chem. Eng. J., (20080000), vol. 144, no. 2008, pages 324 - 328, XP025468203
OPPOSITION- ZIMMERMANN, T. S. et al., "- RNAi-mediated gene silencing in non-human primates", Nature, (20060000), vol. 441, pages 111 - 114, XP002412249
OPPOSITION- SEMPLE, S. C. et al., "Rational design of cationic lipids for siRNA delivery", Nature Biotechnology, (20100201), vol. 8, no. 2, pages 172 - 176, XP002633693
OPPOSITION- RANA TM., "Illuminating the silence: understanding the structure and function of small RNAs", Nat Rev Mol Cell Biol, (20070101), vol. 8, no. 1, pages 23 - 36, XP007916057
SEARCH- KOH CHEE GUAN ET AL, "Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing", JOURNAL OF CONTROLLED RELEASE, (20090828), vol. 141, no. 1, ISSN 0168-3659, pages 62 - 69, XP002715252 [X] 1-9 * page 62 * * abstract * * page 64, paragraph 1 - page 65, paragraph 1 * [I] 10-15
SEARCH- CHEN DELAI ET AL, "Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation.", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (20120425), vol. 134, no. 16, ISSN 1520-5126, pages 6948 - 6951, XP002715254 [T] * the whole document *
SEARCH- BELLIVEAU NATHAN M ET AL, "Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA.", MOLECULAR THERAPY. NUCLEIC ACIDS, (2012), vol. 1, ISSN 2162-2531, pages 1 - 9, XP002715253 [T] * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents